Transbronchial MWA for Pulmonary Tumors

The purpose of the study is to evaluate the efficacy and safety of transbronchial microwave ablation for lung cancer.

Trial Details

NCT ID
NCT06969014
Phase
NA
Sponsor
Shanghai Chest Hospital
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Microwave ablation
Locations (sample)
  • Shanghai, Shanghai Municipality, China|31.22222,121.45806

Key Eligibility Criteria

  • Age ≥18 years old;
  • Pathologically diagnosed as primary peripheral lung cancer, preoperative staging suggested clinical staging as T1N0M0, stage IA (including new-onse…
  • The lesion to be ablated has been evaluated as feasible for microwave ablation treatment under bronchoscopy guidance.
  • Agree to undergo transbronchial MWA as initial treatment after being assessed unsuitable for surgery and radiotherapy or refusing surgery and radio…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →